Dementia

Disease State Hub

News
Research Summaries
Resources
FDA Alerts Pearls of Wisdom From the Journal
Insights
Commentary Podcasts Q&As Videos
Interactive
Polls Quizzes Slideshows
Events & Education

Clinical Insights

Video
Kasia Rothenberg, MD, PhD
Video
Understanding the Signs and Symptoms of Alzheimer Disease-Related Agitation
08/29/2024
In this video, Kasia Rothenberg, MD, PhD, describes Alzheimer disease-related agitation, details the difficulty in testing for Alzheimer disease-related agitation, looks ahead to potential treatment options...
08/29/2024
Conference Coverage
craig chepke
Conference Coverage
Agitation in Alzheimer Dementia: Progress for an Age-Old Problem
04/19/2024
In this video, Craig Chepke, MD, DFAPA, and Kevin Williams, MS, MPAS, PA-C provide the take-home messages from their session “Agitation in Alzheimer’s Dementia: Progress for an Age-Old Problem” at our...
04/19/2024
Video
samar
Video
High Volume of Healthy Vascular Fat During Menopause Associated With Better Brain Health Later in Life
04/14/2024

Samar R El Khoudary, PhD, MPH, BPharm, FAHA

Samar R El Khoudary, PhD, MPH, BPharm...
In a long-term follow-up study, Samar R. El Khoudary, PhD, MPH, BPharm, FAHA, and colleagues investigated how the quantity and quality of cardiovascular fat in women with Alzheimer disease measured during...
04/14/2024
Video
lucey
Video
Small Trial Shows FDA-Approved Insomnia Treatment Decreases Alzheimer Proteins in Healthy Adults
03/25/2024

Brenden P. Lucey, MD, MSCI

Brenden P. Lucey, MD, MSCI
In a small clinical trial, researchers found that patients taking suvorexant, an FDA-approved treatment for insomnia, had reduced levels of amyloid beta (amyloid-β) and tau phosphorylation proteins, which...
03/25/2024
Video
dantas
Video
Altered Gut Microbiota a Potential Indicator of Early Alzheimer Disease
01/28/2024

Gautam Dantas, PhD

Gautam Dantas, PhD
In this video, Gautam Dantas, PhD, discusses how the results of his study showed that altered gut bacteria may be an indicator of the earliest stages of Alzheimer disease.
01/28/2024
expert Q&A
emile d'angremont
expert Q&A
Cholinesterase Inhibitors for Neuropsychiatric Symptoms in Alzheimer Disease, Parkinson Disease
12/31/2023

Emile d’Angremont, MSc

Emile d’Angremont, MSc
In this interview, Emile d’Angremont, MSc, discusses the results of a recent study examining the use of cholinesterase inhibitors for the management of psychotic symptoms among patients with...
12/31/2023
Video
Gillian Coughlan
Video
Age at Menopause, Delayed Hormone Therapy Linked to Elevated Levels of Tau Protein
12/28/2023
In this video, Gillian T. Coughlan, MS, PhD discusses her team's study results, which found that female sex, early-age menopause, and hormone therapy use beginning more than 5 years after menopause were...
12/28/2023
Video
George
Video
Early Adulthood Hypertension Associated With Worse Brain Health Later in Life
12/03/2023
Early adulthood hypertension or increased blood pressure is associated with negative brain changes later in life including lower regional brain volumes and worse white matter integrity, factors that are...
12/03/2023
Conference Coverage
Kevin Williams
Conference Coverage
Preview: Treatment of Agitation in Patients With Alzheimer Dementia
05/24/2023
In this video, Craig Chepke, MD, DFAPA, and Kevin Williams, MS, MPAS, PA-C provide a preview of their session, "Agitation in Alzheimer’s Dementia: Progress for an Age-Old Problem ” at our Practical Updates...
05/24/2023